Affluent Net Income Applicable To Common Shares from 2010 to 2026
| AFME Stock | 2.81 0.01 0.36% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -13.3 M | Current Value -13.9 M | Quarterly Volatility 4.7 M |
Check Affluent Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Affluent Medical's main balance sheet or income statement drivers, such as Interest Income of 352.9 K, Depreciation And Amortization of 1.9 M or Interest Expense of 264.4 K, as well as many indicators such as Price To Sales Ratio of 14.09, Dividend Yield of 0.0 or PTB Ratio of 2.62. Affluent financial statements analysis is a perfect complement when working with Affluent Medical Valuation or Volatility modules.
Affluent | Net Income Applicable To Common Shares |
Analyzing Affluent Medical's Net Income Applicable To Common Shares over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income Applicable To Common Shares has evolved provides context for assessing Affluent Medical's current valuation and future prospects.
Latest Affluent Medical's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Affluent Medical SAS over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Affluent Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Affluent Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Affluent Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (10,867,086) | |
| Coefficient Of Variation | (42.83) | |
| Mean Deviation | 4,391,257 | |
| Median | (13,265,100) | |
| Standard Deviation | 4,654,535 | |
| Sample Variance | 21.7T | |
| Range | 10.8M | |
| R-Value | (0.82) | |
| Mean Square Error | 7.6T | |
| R-Squared | 0.67 | |
| Significance | 0.000055 | |
| Slope | (756,200) | |
| Total Sum of Squares | 346.6T |
Affluent Net Income Applicable To Common Shares History
About Affluent Medical Financial Statements
Affluent Medical stakeholders use historical fundamental indicators, such as Affluent Medical's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Affluent Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Affluent Medical's assets and liabilities are reflected in the revenues and expenses on Affluent Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Affluent Medical SAS. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -13.3 M | -13.9 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Affluent Stock
Affluent Medical financial ratios help investors to determine whether Affluent Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Affluent with respect to the benefits of owning Affluent Medical security.